top of page
Browse by category
Search
MBS achieves greater weight loss with lower ongoing cost vs GLP-1s
Metabolic bariatric surgery (MBS) achieves greater weight loss and lower ongoing cost compared to the glucagon-like peptide-1 receptor...
GLP-1s patients more likely to develop GERD
The incidence of gastroesophageal reflux disease (GERD) is higher among people taking glucagon-like peptide-1 receptor agonists (GLP-1...
GLP-1 RA linked to increased residual gastric content before anaesthesia
Safety concerns for patients undergoing anaesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been revealed in a...
Browse by tag
bottom of page